Damora Therapeutics is trading 6.43% higher at $23.00 on October 29, 2026, with healthcare-sector strength the most relevant available context. - Healthcare sector is up 2.32% during the regular session, while major U.S. indices are lower; the move may reflect sector-level buying. - No new company-specific announcement explaining the move or trading-volume data was identified. The latest listed company release was dated October 2; its next earnings report is scheduled for November 5.